Clinical trial

Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma

NCT01516593

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-11-01

PhasePHASE2

Study timeline

Study start (unknown)2011-11-01Date precision: month

Registry last updated2022-08-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIVunresolved

Burkitt's Lymphomaunresolved

Interventions

Induction PhaseDRUG

Consolidation Phase (on day +50)DRUG

Intensification phaseDRUG

BEAM conditioningDRUG

Consolidation radiotherapyRADIATION

Sponsors & collaborators

Andres J. M. Ferrerilead sponsor

Mapped research locations

MilanItaly3 RomaItaly1 BresciaItaly1 TorinoItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01516593 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.